Spironolactone and endocrine dysfunction

Donald (Lynn) Loriaux, R. Menard, A. Taylor, R. andSanten

Research output: Contribution to journalArticle

96 Citations (Scopus)

Abstract

Therapy with spironolactone is often associated with estrogenlike side effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.

Original languageEnglish (US)
Pages (from-to)630-636
Number of pages7
JournalAnnals of Internal Medicine
Volume85
Issue number5
StatePublished - 1976
Externally publishedYes

Fingerprint

Spironolactone
Gynecomastia
Androgen Antagonists
Erectile Dysfunction
Gonadotropins
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Loriaux, D. L., Menard, R., Taylor, A., & andSanten, R. (1976). Spironolactone and endocrine dysfunction. Annals of Internal Medicine, 85(5), 630-636.

Spironolactone and endocrine dysfunction. / Loriaux, Donald (Lynn); Menard, R.; Taylor, A.; andSanten, R.

In: Annals of Internal Medicine, Vol. 85, No. 5, 1976, p. 630-636.

Research output: Contribution to journalArticle

Loriaux, DL, Menard, R, Taylor, A & andSanten, R 1976, 'Spironolactone and endocrine dysfunction', Annals of Internal Medicine, vol. 85, no. 5, pp. 630-636.
Loriaux DL, Menard R, Taylor A, andSanten R. Spironolactone and endocrine dysfunction. Annals of Internal Medicine. 1976;85(5):630-636.
Loriaux, Donald (Lynn) ; Menard, R. ; Taylor, A. ; andSanten, R. / Spironolactone and endocrine dysfunction. In: Annals of Internal Medicine. 1976 ; Vol. 85, No. 5. pp. 630-636.
@article{189f086b2750404fb3e055f680ecd5ed,
title = "Spironolactone and endocrine dysfunction",
abstract = "Therapy with spironolactone is often associated with estrogenlike side effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.",
author = "Loriaux, {Donald (Lynn)} and R. Menard and A. Taylor and R. andSanten",
year = "1976",
language = "English (US)",
volume = "85",
pages = "630--636",
journal = "Annals of Internal Medicine",
issn = "0003-4819",
publisher = "American College of Physicians",
number = "5",

}

TY - JOUR

T1 - Spironolactone and endocrine dysfunction

AU - Loriaux, Donald (Lynn)

AU - Menard, R.

AU - Taylor, A.

AU - andSanten, R.

PY - 1976

Y1 - 1976

N2 - Therapy with spironolactone is often associated with estrogenlike side effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.

AB - Therapy with spironolactone is often associated with estrogenlike side effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.

UR - http://www.scopus.com/inward/record.url?scp=0017189578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017189578&partnerID=8YFLogxK

M3 - Article

C2 - 984618

AN - SCOPUS:0017189578

VL - 85

SP - 630

EP - 636

JO - Annals of Internal Medicine

JF - Annals of Internal Medicine

SN - 0003-4819

IS - 5

ER -